Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO
Sofia Nascimento dos Santos, Melinda Wuest, Hans-Sonke Jans, Jenilee Woodfield, Arian Pérez Nario, Daniel Krys, Jennifer Dufour, Darryl Glubrecht, Cody Bergman, Emerson Soares Bernardes, Frank Wuest
Topics & Concepts
BiodistributionIn vivoChemistryMisonidazoleHypoxia (environmental)In vitroImaging agentTumor hypoxiaNitroimidazoleBreast cancerPositron emission tomographyCancer researchPharmacologyNuclear medicineCancerMedicineRadiation therapyInternal medicineBiochemistryBiologyOrganic chemistryOxygenBiotechnologyCancer, Hypoxia, and MetabolismNanoplatforms for cancer theranosticsMedical Imaging Techniques and Applications